国际皮肤性病学杂志    2003 29 (5): 297-299   ISSN: 2096-5540  CN: 32-1880/R   中毒性表皮坏死松解症研究进展 汪盛, 李利 四川大学华西医院皮肤性病科 成都 610041 收稿日期 2002-12-24  修回日期 null  网络版发布日期 null 参考文献  [1] Fritsch PO,Sidoroff A.Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.Am J Clin Dermatol,2000,1(6):349-360. [2] Paul C,Wolkenstein P,Adle H,et al.Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis.Br J Dermatol,1996,134(4):710-714. [3] Friedmann PS,Strickland I,Pirmohamed M,et al.Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine.Arch Dermatol,1994,130(5):598-604. [4] Stone N,Sheerin S,Burge S.Toxic epidermal necrolysis and graft vs.host disease:a clinical spectrum but a diagnostic dilemma.Clin Exp Dermatol,1999,24(4):260-262. [5] Magina S,Lisboa C,Goncalves E,et al.A case of toxic epidermal necrolysis treated with intravenous immunoglobin.Br J Dermatol,2000,142(1):191-192. [6] Paquet P,Jacob E,Damas P,et al.Treatment of drug-induced toxic epidermal necrolysis(Lyell's syndrome) with intravenous human immunoglobulins.Burns,2001,27(6):652-655. [7] Correia O,Delgado L,Roujeau JC,et al.Soluble interleukin 2 receptor and interleukin 1alpha in toxic epidermal necrolysis:a comparative analysis of serum and blister fluid samples.Arch Dermatol,2002,138(1):29-32. [8] Correia O,Delgado L,Barbosa IL,et al.CD8+ lymphocytes in the blister fluid of severe acute cutaneous graft-versus-host disease:further similarities with toxic epidermal necrolysis.Dermatology,2001,203(3):212-216. [9] Krammer PH.CD95's deadly mission in the immune system.Nature,2000,407(6805):789-795. [10] Wolkenstein P,Latarjet J,Roujeau JC,et al.Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis.Lancet,1998,352(9140):1586-1589. [11] Lee SH,Jang JJ,Lee JY,et al.Fas ligand is expressed in normal skin and in some cutaneous malignancies.Br J Dermatol,1998,139(2):186-191. [12] Viard I,Wehrli P,Bullani R,et al.Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.Science,1998,282(5388):490-493. [13] French LE,Tschopp J.Fas-mediated cell death in toxic epidermal necrolysis and graft-versus-host disease:potential for therapeutic inhibition.Schweiz Med Wochenschr,2000,130(44):1656-1661. [14] Nassif A,Bensussan A,Dorothee G,et al.Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis.J Invest Dermatol,2002,118(4):728-733. [15] Stella M,Cassano P,Bollero D,et al.Toxic epidermal necrolysis treated with intravenous high-dose immunoglobulins:our experience.Dermatology,2001,203(1):45-49. [16] Hess DA,Rieder MJ.The role of reactive drug metabolites in immune-mediated adverse drug reactions.Ann Pharmacother,1997,31(11):1378-1387. [17] Kalgutkar AS,Dalvie DK,O'Donnell JP,et al.On the diversity of oxidative bioactivation reactions on nitrogen-containing xenobiotics.Curr Drug Metab,2002,3(4):379-424. 通讯作者: